BUZZ-Pfizer rises on better-than-expected quarterly results

Shares of drugmaker Pfizer PFE.N rise ~2% to $26.72 premarket

Co reports Q4 adj. profit of 63 cents per share, above analysts' est. of 47 cents, according to data compiled by LSEG, driven by strong sales of its heart disease drug and COVID-19 vaccine sales

Co posts Q4 sales of $17.76 bln vs analysts' est. of $17.36 bln - LSEG

Q4 sales of heart disease drug, sold as Vyndaqel and Vyndamax, came in at $1.55 bln, above estimates of $1.48 bln - LSEG

COVID vaccine Comirnaty brought in sales of $3.38 bln, above analysts' est. of $3.10 bln - LSEG

PFE fell 10.8% in 2024